2m 2m 2m 2m 2m 2m 2m
ATTOVIA THERAP (ATTO)
NASDAQ
$14.83-$0.98 (-6.19%)
Price as of Nov 13, 2026 12:50 PM EST- $722.7MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
ATTOVIA THERAP (ATTO)
$14.83-$0.98 (-6.19%)
ATTO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.81 | ||
Change | -$0.92 (-5.50%) | ||
Open | $16.50 | ||
High | $16.79 | ||
Low | $15.41 | ||
Previous Close | $16.73 | ||
Volume | 222,107 | ||
30-Day Average Volume | 323,401 | ||
1-Week Change | 5.40% | ||
1-Month Change | 8.36% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.7M | ||
Total Assets | $411.8M | ||
Market Cap | $722.7M | ||
Enterprise Value | $607.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$22.3M | ||
Free Cash Flow | N/A | ||
EBIT | -$22.3M | ||
EBITDA | -$22.1M | ||
Net Working Capital | $392.8M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | -0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/09/2017 | ||
Last Split Factor | 1 : 5.0270904666729 | ||
Last Split Date | 07/30/2020 | ||